Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?Julia S. Johansen, Paul A. Price, Benny Vittrup Jensen et al.|Cancer Epidemiology Biomarkers & Prevention|2006Cited by 364
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.M. Ryberg, P Dombernowsky, Dorte Nielsen et al.|Journal of Clinical Oncology|1998Cited by 285
Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal CancerIvano Bertini, Paola Turano, Stefano Cacciatore et al.|Cancer Research|2011Cited by 203